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The prevalence of insulin resistance and type 2 diabetes (T2D) in obese youth is rapidly increasing, especially in Hispanics and
African Americans compared to Caucasians. Insulin resistance is known to be associated with increases in intramyocellular
(IMCL) and hepatic fat content. We determined if there are ethnic differences in IMCL and hepatic fat content in a multiethnic
cohort of 55 obese adolescents. We used
1H magnetic resonance spectroscopy (MRS) to quantify IMCL levels in the soleus
muscle, oral glucose tolerance testing to estimate insulin sensitivity, magnetic resonance imaging (MRI) to measure abdominal
fat distribution. Liver fat content was measured by fast–MRI. Despite similar age and % total body fat among the groups, IMCL
was significantly higher in the Hispanics (1.71% [1.43%, 2.0%]) than in the African-Americans (1.04% [0.75%, 1.34%], p=0.013)
and the Caucasians (1.2% [0.94%, 1.5%], p=0.04). Liver fat content was undetectable in the African Americans whereas it was
two fold higher than normal in both Caucasians and Hispanics. Visceral fat was significantly lower in African Americans
(41.5 cm
2 [34.6, 49.6]) and was similar in Caucasians (65.2 cm
2 [55.9, 76.0]) and Hispanics (70.5 cm
2 [59.9, 83.1]). In a multiple
regression analysis, we found that ethnicity independent of age, gender and % body fat accounts for 10% of the difference in
IMCL. Our study indicates that obese Hispanic adolescents have a greater IMCL lipid content than both Caucasians and African
Americans, of comparable weight, age and gender. Excessive accumulation of fat in the liver was found in both Caucasian and
Hispanic groups as opposed to virtually undetectable levels in the African Americans. Thus, irrespective of obesity, there seem
to be some clear ethnic differences in the amount of lipid accumulated in skeletal muscle, liver and abdominal cavity.
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Adolescents. PLoS ONE 2(6): e569. doi:10.1371/journal.pone.0000569
INTRODUCTION
In African-American and Hispanic youth, T2DM is more common
than in individuals of Caucasian origin [1]. The ethnicity-related
higher prevalence of T2DM is attributed to a greater degree of
obesity and severity of insulin resistance[2]. Indeed, several studies
have demonstrated decreased insulin sensitivity and hyperinsuli-
nemia in healthy African-American and Hispanic children com-
pared with their Caucasian peers [3,4,5]. The reasons for these
ethnic differences have not yet been elucidated.
Hispanic Americans are the second largest and fastest growing
ethnic group in the US. Current data on immigration trends to the
US indicate that by the year 2050 over 25% of the population will
be represented mainly by Hispanics. Hence, in the near future we
will witness an increase in the prevalence of diabetes in the US
population of much larger proportion than what has been
observed thus far [6].
Insulin resistance plays a major role in the pathogenesis of type
2 diabetes and is strongly linked to increased intracellular fat
content in both skeletal muscle and liver [7,8]. More specifically,
intracellular accumulation of diacylglycerols (DAG), is increasingly
recognized as a possible mediator of alteration in insulin signaling
in both skeletal muscle [7] and liver tissues [8,9]. Both skeletal
muscle tissues and the liver are major loci of insulin resistance in
obesity. The overall goal of this study was to determine whether
the lipid partitioning in skeletal muscle tissue and liver differ in
obese African-American, Hispanic and Caucasian youth, of
similar age, and % total body fat.
1H-MRS was used to quantify
non-invasively the intra and extra myocellular (IMCL and EMCL)
lipid content of the soleus muscle and fast-gradient echo magnetic
resonance pulse sequences (fast-MRI), enabled the measurement
of intra-hepatic fat accumulation in a single breath-hold. MRI
allowed the assessment of abdominal fat distribution. In addition,
insulin sensitivity was estimated using the oral glucose tolerance
tests (OGTT) in all subjects and related to intramyocellular,
intrahepatic fat content and visceral fat in obese adolescents of
different ethnic groups.
METHODS
Participants
We studied three groups of overweight and obese subjects: 21
Caucasian, 17 African-American and 17 Hispanic adolescents
(total n=55), recruited from The Pediatric Obesity Clinic at Yale
University. To be eligible for this study, subjects had to be
overweight or obese, (BMI.85
th or 95
th age and gender specific),
to be taking no medications that can alter glucose metabolism, and
to be otherwise healthy. In all participants we did a complete
physical examination and took a detailed medical history. Ethnicity
was determined by self-report. Subjects were asked two separate
questions–one on ethnicity and one on race. The ethnicity infor-
mation was collected first followed by the question on race.
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racial category. The study was approved by the Human
Investigational Committee of the Yale School of Medicine.
Written informed consent was obtained from the parents, and
written assent was given by the participants.
Metabolic Studies
Oral Glucose Tolerance Test (OGTT) All subjects were
invited to the Yale General Clinical Research Center for an
OGTT at 8 a.m. following an overnight fast, as previously
reported [10]. The subjects were instructed to consume a diet
containing at least 250 g of carbohydrates the day prior to the
study and to refrain from vigorous physical activity. Baseline blood
samples were obtained from subjects while they were fasting, with
the use of an indwelling venous line for measurement of levels of
glucose, insulin, lipid profile, free fatty acids (FFAs), adiponectin
and leptin. A standard 3-hr OGTT was then performed with the
administration of 1.75 g of glucose per kg body weight (maximum
dose: 75 g), and blood samples were obtained every 30 minutes for
the measurement of plasma glucose, insulin and c-peptide [10].
Imaging Studies
1H-NMR Spectroscopy: Intramyocellular Triglyceride
Content Muscle TG content was measured using a 4.0T
Biospec system (Bruker Biospin MRI GmbH, Ettlingen, Germany)
usingthefollowingprotocol:subjectswerepositionedsupine withthe
calf muscle of their right leg placed within a coil assembly consisting
of two
1H-surface coils (13 cm diameter) arranged spatially to
generate a quadrature field. Once inserted into the isocenter of the
magnet, the probe was tuned and matched, and scout images of the
lower leg were obtained to ensure correct positioning of the subject
and todefinea volumeof interestwithinthe soleusmuscle.Localized
shimming was performed using the FASTMAP procedure [11] and
typical
1H linewidths within the volume of interest were ,14Hz.
Following pulse calibration, localized proton spectra were acquired
from a 10610610 mm
3 voxel using a STEAM sequence (excitation
pulse 2ms (SLR90), TR 2.5s, TE 15ms, TM 15ms 2500Hz, #2048
points over 2500Hz), with 3 modules of CHESS water suppression.
To prevent voxel mis-registration due to chemical shift effects, total
lipid content was estimated from the comparison of two spectra:
a water-suppressed lipid spectrum (128 scans) and a lipid-suppressed
water spectrum (64 scans), with the appropriate peak for each
spectrum on-resonance.
1H free induction decays (FIDs) were processed using
XWINNMR version 6.5 (Bruker Biospin, Germany); FIDs were
zero-filled to 32 k points and multiplied by a Lorentzian/Gaussian
function (lb-2/gb 0.15) prior to Fourier transformation. After
phase and baseline correction, the resonances of each spectrum
were fitted using the Nuts-PPC Software package (Acorn NMR,
Inc., CA, USA). The lipid spectrum was deconvoluted by fitting up
to 8 resonances over the region from 1.5 to 0.8 ppm using the
creatine signal at 3.0 ppm as reference. The areas of the EMCL,
IMCL and water resonances were corrected for T1 and T2
relaxation. EMCL and IMCL content was expressed as a percent-
age of the water content.
Fast-MRI: Liver Fat Content Measurement of hepatic fat
accumulation was performed using MRI along with the Dixon
method as modified by Fishbein et al [12]. The method is based on
phase-shift imaging where hepatic fat fraction (HFF) is calculated
from the signal difference between the vectors resulting from in-
phase and out-of-phase signals. One hepatic slice pair was
obtained during a breath-hold of 15 seconds. Using the MRIcro
software program, five regions of interest were drawn on each
image, and the mean pixel signal intensity level was recorded. The
HFF was calculated in duplicate from the mean pixel signal
intensity data using the formula: [(Sin-Sout)/(2*Sin)]*100. This
technique was introduced at a later stage of the study; therefore, it
was performed in a smaller cohort of subjects (8 African-
Americans, 8 Hispanics, and 11 Caucasians). In our group the
technique of fast–MRI was validated against the
1H-MRS of the
liver in a group of 20 subjects and we found a strong agreement
between the two techniques (r=0.94, p=0.001) (personal data
from Drs Caprio, Gerald Shulman and Todd Constable).
Abdominal MRI: Intra-abdominal and subcutaneous fat
depot Abdominal MRI studies were performed on a Siemens
Sonata 1.5-Tesla system. The pulse sequence was a T1-weighted
Fast Low Angle Shot Gradent Echo (FLASH). Slices were
acquired using a 400cm field of view (TE:4.76, TR:100, 4
excitations, 90u flip angle, matrix: 2566128, bandwidth:140). The
mid-axial section was positioned to pass through the L4/L5 disc
space. Images were imported into the Yale Bioimage Suite
software package [13]. Visceral, subcutaneous, deep subcutaneous
and superficial subcutaneous fat areas were determined from the
mid-axial slice. The fascia superficialis was used as the division
between the deep and superficial subcutaneous fat. Thresholding
was applied to separate fat from soft tissue.
DEXA Total body composition was measured by dual-energy
X-ray absorptiometry with a Hologic scanner (Boston, MA, USA).
Analytical Procedures and Calculations
Plasma glucose levels were measured using the YSI 2700 STAT
Analyzer (Yellow Springs Instruments), and lipid levels were
measured using an Autoanalyzer (model 747-200, Roche-Hitachi).
Plasma adiponectin levels were measured by a double antibody-
antibody RIA assay from Linco by our research laboratory. The
intra- and inter-assay coefficients of variation are 7.1% and 9.5%,
respectively. Plasma insulin and leptin levels were measured using
an RIA assay from Linco (insulin intra- and inter-assay coefficients
of variation: 6.8% and 11.6%, respectively; leptin intra- and inter-
assay coefficients of variation: 6.5% and 8.0%, respectively).
Estimated insulin sensitivity was calculated using the Matsuda
index (whole-body insulin sensitivity index (WBISI), which has
been validated by comparison with hyperinsulinemic-euglycemic
clamp studies in obese children and adolescents [14–15].
Statistical Analysis
Data are represented as mean6SD, SEM, or 95% confidence
intervals, as appropriate. Parameters that were not normally
distributed were log-transformed for analysis. Multiple pair-wise
comparisons of subjects were performed using ANOVA with post-
hoc Bonferroni correction for multiple comparisons between pairs.
Adjustment ofcomparisons forpotentialconfounders wasperformed
using analysis ofcovariancewith maineffects for age, sex, percent fat
andotherrelevantcovariateswhereappropriate.Pearsoncorrelation
analysiswasusedwhenapplicabletoexaminebivariaterelationships.
To examine the independent association between IMCL, visceral
fat, and ethnicity we used multiple regression analysis. A p-value of
,0.05 was considered statistically significant. All analyses were
performed using SPSS 14.0 for Windows.
RESULTS
Anthropometric Characteristics of the Cohort
(Table 1)
As reported in Table 1, in the entire cohort, the distribution of sex
was not significantly different across ethnicity (p=1.00). The three
Differences in Fat Deposition
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and BMI z-score were not significantly different among the three
groups. Moreover, assessment of whole body composition by
DEXA, revealed no significant differences in percent fat, lean
body mass, and total body fat mass among the three groups.
Metabolic Profile of the Cohort (Table 2)
The metabolic profile of the participants was in most aspects very
similar across ethnicity (Table 2). After adjusting for age, sex, and
percent body fat, there was no significant ethnicity main effect or
ethnicity*sex interaction in fasting glucose, two-hour glucose,
fasting insulin and the 2 hour insulin levels among the groups.
Insulin sensitivity, as measured by WBISI tended to be lower in
the Hispanic group, there was however no significant ethnicity
main effect or ethnicity*sex interaction in insulin sensitivity. For
the lipid profile, total cholesterol and LDL concentrations were
similar among the three groups. African Americans tended to have
lower triglyceride levels and higher HDL-C than both Caucasians
and Hispanics. Leptin and adiponectin levels were similar across
ethnicity.
Muscle, liver and Abdominal lipid Partitioning
(Figure 1)
As shown in Figure 1, despite a similar degree of overall adiposity,
IMCL was significantly higher in the Hispanic group (1.71%, 95%
CI: 1.43%, 2.0%) than in the African-American (1.04%, 95% CI:
0.75%, 1.34%) and the Caucasian (1.2%, 95% CI: 0.94%, 1.5%)
groups (p=0.013 and p=0.04 respectively). In contrast, EMCL
levels were not significantly different among the Caucasian
(1.78%, 95% CI: 1.43%, 2.1%), African-American (1.81%, 95%
Table 1. Anthropometric Characteristics (mean6SD)
......................................................................
Caucasian African-American Hispanic
N 21 17 17
Gender (M/F) 11/10 6/11 11/6
Age (yrs) 14.661.84 14.762.73 15.262.4
Weight (kg) 100.2616.6 103.0619.7 103.0622.0
Height (cm) 168.069.8 165.2612.2 166.4610.0
BMI (kg/m
2) 35.765.72 37.465.5 37.066.0
BMIz 2.3060.27 2.460.24 2.460.35
%Fat 40.366.55 41.265.8 38.7465.53
Total Fat Mass (kg) 39.4612.0 40.37610.5 39.04611.0
Lean Body Mass (kg) 57.069.42 59.2611.8 59.45614.6
doi:10.1371/journal.pone.0000569.t001
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Table 2. Metabolic profile of the cohort, adjusted for age, gender and percent body fat.
..................................................................................................................................................
Caucasian African-American Hispanic
Fasting Glucose (mg/dl)
Mean (95% CI) 90.63 (87.3, 94.0) 91.6 (88.0, 95.4) 92.0 (88.2, 95.8)
Fasting Insulin (mU/ml)
Geometric Mean (95% CI) 30.85 (24.8, 38.3) 28.33 (22.0, 36.7) 35.0 (27.3, 45.0)
2-hour Glucose (mg/dl)
Mean (95% CI) 114.7 (104.7, 124.7) 117.1 (106.0, 128.2) 111.0 (100.5, 122.0)
2-hour Insulin (mU/ml)
Geometric Mean (95% CI) 124.3 (82.7, 187.0) 151.0 (93.2, 244.4) 116.4 (75.6, 179.1)
WBISI
Geometric Mean (95% CI) 1.55 (1.17, 2.06) 1.65 (1.2, 2.3) 1.32 (1.0, 1.83)
HOMA-IR
Geometric Mean (95% CI) 6.8 (5.6, 8.5) 6.34 (5.0, 8.1) 7.9 (6.23,10.0)
Total Cholesterol (mg/dl)
Mean (95% CI) 151.5 (129.0, 174.1) 148.3 (123.0, 174.0) 140.2 (116.0,164.8)
HDL (mg/dl)
Mean (95% CI) 39.0 (33.14, 44.8) 47.13 (40.5, 53.7) 38.3 (32.0, 45.0)
LDL (mg/dl)
Mean (95% CI) 86.0(65.1, 106.2) 82.2 (59.0, 106.0) 81.4 (59.0, 104.0)
Triglycerides (mg/dl)
Geometric Mean (95% CI) 93.4 (65.8, 132.7) 80.2 (53.8, 119.3) 94.4 (64.4, 138.4)
FFA (mmol/L)
Geometric Mean (95% CI) 466.4 (363.2, 598.8) 377.3 (279.0, 510.3) 534.0 (407.1, 701.0)
Leptin (ng/ml)
Geometric Mean (95% CI) 23.3 (20.0, 27.1) 28.0 (24.0, 33.0) 23.0 (19.3, 26.3)
Adiponectin (mg/ml)
Geometric Mean (95% CI) 8.14 (5.6, 11.8) 8.7 (5.5, 13.7) 7.8 (5.2, 12.0)
doi:10.1371/journal.pone.0000569.t002
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2.4%) (data not shown).
While intrahepatic fat content, expressed as hepatic fat fraction
(HFF) was undetectable in the AA obese adolescents, in the
Caucasian HFF it was 17.5% and in the Hispanics 13%. These
elevated HFF levels denote increased lipid accumulation in the
liver since they are well above the accepted normal reference value
of 5.5% [16].
Abdominal visceral fat was significantly lower in the African-
American group (49.8 cm
2, 95% CI: 38.0, 61.7 cm
2) compared to
Figure 1. Visceral fat, subcutaneous fat (total, deep, and superficial), intramyocellular lipid (IMCL), and hepatic fat fraction by ethnicity
(mean6SEM, adjusted for age, gender, and percent fat).
doi:10.1371/journal.pone.0000569.g001
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2, 95% CI: 65.0, 86.0 cm
2) and Hispanic
(83.0 cm
2, 95% CI: 70.7, 95.0 cm
2) groups (p=0.01 and
p=0.003, respectively), after adjusting for age, sex, and percent
body fat. Total subcutaneous fat was similar in the African-
American group (589.0 cm
2, 95% CI: 534.0, 644.1 cm
2) , in the
Caucasian group (559.0 cm
2, 95% CI: 510.3, 607.3 cm
2) and the
Hispanic group (577.0 cm
2, 95% CI: 521.3, 632.4 cm
2).W e
further divided the subcutaneous fat into deep and superficial and
found that there were no significant differences in the deep
subcutaneous fat between the three groups. In contrast, the
African American group had a significantly higher amount of
superficial subcutaneous fat (180.3 cm
2, 95% CI: 159.0,
202.0 cm
2) than the Caucasian group (139.5 cm
2, 95% CI:
121.0, 158.1 cm
2) but not compared to the Hispanic group
(145.2 cm
2, 95% CI: 124.0, 166.5 cm
2). The Caucasian and
Hispanic groups were similar with respect to all abdominal depots.
To further illustrate the marked ethnic differences in IMCL, HFF
and abdominal fat partitioning we chose one boy from each group.
As shown in Figure 2, the 3 boys had similar age and % total body
fat. Nevertheless, while the Hispanic boy had marked elevation in
IMCL,HFF and visceral fat,the AAboy, incontrasthad low IMCL,
undetectable liver fat and low visceral fat and marked expansion of
the total subcutaneous fat. The Caucasian boy had a low IMCL and
liver fat but significant visceral fat content.
Relationships between IMCL, Hepatic Fat fraction,
Visceral fat, and Insulin Sensitivity (Figure 3)
Using univariate analysis in the entire cohort, significant inverse
relationships were found between insulin sensitivity (WBISI)
and IMCL (r=20.268; p=0.05), hepatic fat content (HFF)
(r=20.384, p=0.04), and with visceral adiposity (r=20.468;
p=0.001) (Figure 3).
To further analyze to what degree any differences in IMCL and
Visceral fat may be accounted for by ethnic differences we used
a stepwise multiple regression analysis to determine whether the
effect of ethnicity remained after adjusting for confounding
variables such as gender, age and % body fat. Of note, ethnicity
alone explained 10% of the variance of IMCL (r
2=0.103,
p,0.02), and this relationship was not affected by entering age,
gender and % body fat to the model. On the other hand, ethnicity
alone was not found to significantly account for differences in
visceral fat. Indeed, better predictors for visceral fat were gender
and % total body fat. In a multiple regression analysis using
WBISI as the dependent variable and ethnicity, gender, IMCL,
visceral and HFF as independent variables, we found that ethnicity
explained 10.4% (p,0.078) and visceral 32.3% (p,0.01) of the
variance in insulin sensitivity.
DISCUSSION
Our study compared IMCL level, determined by
1H-MRS and
liver fat determined by fast-MRI, across ethnicity in a pediatric
population of obese adolescents with normal glucose tolerance.
Given the higher incidence of insulin resistance and T2DM in
minority populations, we hypothesized that obese Hispanic and
African-American youth would have higher IMCL and liver fat
content than their Caucasian counterparts. Surprisingly, our study
showed that African-Americans had lower IMCL and liver fat
content than Hispanics. In contrast, the Hispanic adolescents in
our study had significantly higher IMCL levels compared to their
Caucasian and African-American peers, and had a significantly
greater lipid content in the liver than the African Americans. Our
data suggest that obese Hispanic adolescents have a higher
propensity to accumulate excess lipid inside the myocyte, in
contrast to obese Caucasians and African-Americans. The ethnic
differences in IMCL are independent of age, gender and overall
Figure 2. Representative abdominal MRI image, liver scans and
1H-MRS of soleus muscle spectra from one Caucasian, one African American, and
one Hispanic boy.
doi:10.1371/journal.pone.0000569.g002
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like that of the Caucasians had a twofold increase in hepatic fat
fraction than the AA group. Indeed, a recent population-based study
of obese adolescents found that Non Alcoholic Fatty Disease
(NAFLD) is more prevalent in Hispanics than in Caucasians, and is
the least common in African Americans [17]. It is unclear why
Hispanics tend to be more susceptible to liver and IMCL
accumulation. Possible causes of these different phenotypes include
genetic factors in the metabolic processing and storage of excess fat
and/or environmental differences such as diet and exercise. It is very
likely that the increased susceptibility of Hispanics to deposit lipid
inside the liver and myocyte plays an important role in their
increased risk of developing insulin resistance, T2DM, and other
metabolic dysfunction. In accordance with the increased IMCL are
the higher levels of plasma free fatty acids we found in Hispanics as
compared to African Americans. These elevated levels of free fatty
acids maylead toanincreased fluxto theliver andmuscle,leading to
the formation of lipid moieties such as diacylglycerol and ceramide,
which have been shown to alter insulin signaling and thus lead to
insulin resistance [7,8].
Our study reaffirmed that the regional abdominal fat distribu-
tion in African-American adolescents is very different from that of
Figure 3. Relationships between IMCL, Hepatic Fat Fraction (HFF), Visceral Fat, and insulin sensitivity (WBISI) in all 3 ethnic groups.
doi:10.1371/journal.pone.0000569.g003
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gender. Consistent with other studies [4,5,21] the African-
American group in our study had significantly lower visceral fat
than the Caucasian and Hispanic groups. In addition, we further
divided the subcutaneous fat into deep and superficial sub-
cutaneous, using the fascia superficialis as the partition. We found
in the African-Americans a greater amount of superficial sub-
cutaneous fat as compared to Caucasians. In line with the lower
visceral fat content, we found African Americans to have
undetectable levels of intrahepatic fat, which is consistent to the
low prevalence rate of fatty liver reported in this ethnic population
by Schwimmer et al [17]. Thus, in African American obesity seems
to spare excessive accumulation of fat not only in the visceral
compartment but also in the liver and muscle (IMCL). Of note,
low level of visceral fat accumulation and excess of subcutaneous
abdominal fat have been reported among individuals of African
descents, whether resident in the US, the Caribbean, South
America or Europe [18]. The mechanism for the ethnic disparities
in fat partitioning has not been elucidated.
It is possible that factors similar to those that protect African-
Americans from accumulating visceral fat may also be responsible
for their lower liver and IMCL lipid content. Our study suggests
that the higher rates of insulin resistance that have been observed
in the African-American population cannot be attributed to
increased visceral fat or IMCL. Of note, despite their lower
visceral fat and lower IMCL levels, African-Americans in our
study had a similar degree of insulin resistance to the other groups.
It seems clear that the fat compartments we analyzed are not
directly responsible for the insulin resistance observed in African-
Americans. It is likely that the pathogenesis of insulin resistance
and T2DM in African-Americans is linked to a mechanism other
than abnormal fat deposition. The low level of both visceral and
intrahepatic fat in the African Americans may explain their better
lipid profile and the lower prevalence rate of metabolic syndrome
seen in this ethnic group [19].
Interestingly, while several studies have shown that African-
American and Hispanic adolescents are more insulin resistant than
Caucasian adolescents [2–5,21]; in our study insulin sensitivity as
measured by the OGTT was not significantly different among the
three groups. However, this finding is not surprising considering
that our study consisted of a very homogenous obese group. Bacha
et al [21] made a similar observation when comparing insulin
sensitivity between Caucasian and African-American obese
adolescents, ascribing the similarity in insulin sensitivity to the
overriding effect of obesity-related insulin resistance that masked
ethnicity-related differences in insulin sensitivity. The cross-
sectional nature of this study does not allow us to deduce
a cause-effect relationship. Further limitations are due to the lack
of information on physical fitness and composition of their diet.
Although the ethnic differences in fat partitioning were readily
apparent we believe that our findings need confirmation in larger
groups of obese children of different ethnicity.
In conclusion our study suggests that obese Hispanic adolescents
have greater IMCL lipid content than both Caucasians and
African Americans, with comparable % fat, age and gender.
Excessive accumulation of fat in the liver was found in both
Caucasian and Hispanic groups as opposed to virtually undetect-
able levels in the African American obese adolescents. Thus,
despite a seemingly overall degree of obesity, there seem to be
some distinct ethnic differences in the amount of lipid accumulated
in skeletal muscle, liver and abdominal cavity. The increased
IMCL and liver fat content in the obese Hispanic adolescents has
important implications for future health in this ethnic group, given
that both phenotypes are associated with T2DM and steatohepa-
titis which may progress to more serious hepatic conditions at
a very young age. Moreover, our study would suggest that these
ethnic differences in tissue lipid partitioning should be considered
when designing an intervention study to prevent or treat the
associated complications of obesity in youth.
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